chartexchange

EXAS
Exact Sciences Corp
stockNASDAQ

InactiveMar 20, 2026
104.91USD+0.953%(+0.99)21,561,523
Loading…
Loading…
Sector
Healthcare
Industry
Medical Diagnostics & Research
CEO
Kevin Conroy
HQ
Madison, Wisconsin, USA
EXAS Profile

exact sciences is a molecular diagnostics company focused on colorectal cancer. the company has exclusive intellectual property protecting its non-invasive, molecular screening technology for the detection of colorectal cancer. stool-based dna (sdna) technology is included in the colorectal cancer screening guidelines of the american cancer society and the u.s. multi-society task force on colorectal cancer. for more information on exact sciences'​ noninvasive colon cancer screening test, visit cologuardtest.com

EXAS Performance
PeriodPriceDateChange